Scholarlink

Background <p>Both lung cancer and diabetes are the leading causes of death worldwide. These two conditions commonly coexist, especially in older patients, and result in worsening of prognosis and lower survival rates. Very limited scientific data are available about their correlation. Studying the mortality trends using data from Centers for Disease Control and Prevention Wide-Ranging Online Data of Epidemiologic Research (CDC WONDER) can help us in designing better health policies and treatment strategies.</p> Methods <p>We analyzed the US mortality data from 1999 to 2023 using the CDC WONDER dataset. The ICD-10 codes were used. For lung cancer, it is C34, and for diabetes, they are E10-14. Temporal trends were analyzed by using joinpoint regression (V5.4.0) and a p value &lt; 0.05 was considered statistically significant.</p> Results <p>From 1999 to 2023, a total of 174,418 deaths were reported in the United States. Most of them occurred at home (39.6%), followed by medical facilities (33.8%). Men had mortality rates approximately twice as high as those of women. Non-Hispanic Black individuals had age adjusted mortality rates (AAMRs) approximately 2 to 3 times higher than other racial groups, peaking at 5.28 in 2005, followed by NH White, NH Other, and Hispanic or Latino, respectively. Rural areas consistently exhibited higher mortality rates. The highest AAMR was found in Kentucky (5.70), followed by West Virginia (5.24) and Oklahoma (4.94). The Southern states had a higher mortality burden.</p> Conclusion <p>The rate of mortality due to lung cancer in diabetics continued to rise, with significant disparities. The research emphasizes the need for smoking cessation strategies, integrated care of diabetes and oncology, and equitable health care access to reduce the disparities.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lung cancer mortality among adults with diabetes: a retrospective analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月24日

查看全文
  • Sarim Hassan Shahab,
  • Mehreen Maka,
  • Siddique Ahmed,
  • Warda Imran,
  • Aoun Hassan,
  • Maria Baig,
  • Muhammad Kashan,
  • Omar Abdullah Gill

摘要

Background

Both lung cancer and diabetes are the leading causes of death worldwide. These two conditions commonly coexist, especially in older patients, and result in worsening of prognosis and lower survival rates. Very limited scientific data are available about their correlation. Studying the mortality trends using data from Centers for Disease Control and Prevention Wide-Ranging Online Data of Epidemiologic Research (CDC WONDER) can help us in designing better health policies and treatment strategies.

Methods

We analyzed the US mortality data from 1999 to 2023 using the CDC WONDER dataset. The ICD-10 codes were used. For lung cancer, it is C34, and for diabetes, they are E10-14. Temporal trends were analyzed by using joinpoint regression (V5.4.0) and a p value < 0.05 was considered statistically significant.

Results

From 1999 to 2023, a total of 174,418 deaths were reported in the United States. Most of them occurred at home (39.6%), followed by medical facilities (33.8%). Men had mortality rates approximately twice as high as those of women. Non-Hispanic Black individuals had age adjusted mortality rates (AAMRs) approximately 2 to 3 times higher than other racial groups, peaking at 5.28 in 2005, followed by NH White, NH Other, and Hispanic or Latino, respectively. Rural areas consistently exhibited higher mortality rates. The highest AAMR was found in Kentucky (5.70), followed by West Virginia (5.24) and Oklahoma (4.94). The Southern states had a higher mortality burden.

Conclusion

The rate of mortality due to lung cancer in diabetics continued to rise, with significant disparities. The research emphasizes the need for smoking cessation strategies, integrated care of diabetes and oncology, and equitable health care access to reduce the disparities.

Graphical Abstract